Search

Search Constraints

You searched for: Author/Creator Overman, Michael

Search Results

1. Ascites and resistance to immune checkpoint inhibition in dMMR/MSI-H metastatic colorectal and gastric cancers. Issue 2 (2nd February 2022)

3. Efficacy of pembrolizumab in patients with advanced cancer of unknown primary (CUP): a phase 2 non-randomized clinical trial. Issue 5 (20th May 2022)

4. Impact of hypofractionated and standard fractionated chemoradiation before pancreatoduodenectomy for pancreatic ductal adenocarcinoma. Issue 17 (31st May 2016)

5. Modified gemcitabine plus nab‐paclitaxel regimen in advanced pancreatic ductal adenocarcinoma. (9th June 2020)

6. Pathological response following neoadjuvant immunotherapy in mismatch repair-deficient/microsatellite instability-high locally advanced, non-metastatic colorectal cancer: Neoadjuvant checkpoint inhibition in locally advanced colorectal cancer. Issue 6 (4th April 2022)

7. Pathological Tumor Response Following Immune Checkpoint Blockade for Deficient Mismatch Repair Advanced Colorectal Cancer. (5th June 2020)

8. Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma. Issue 1 (December 2016)

9. Postoperative Chemotherapy Benefits Patients Who Received Preoperative Therapy and Pancreatectomy for Pancreatic Adenocarcinoma. Issue 6 (June 2020)

10. Prognosis Associated With CA19-9 Response Dynamics and Normalization During Neoadjuvant Therapy in Resected Pancreatic Adenocarcinoma. Issue 3 (26th March 2023)